Pulmonary Disease in Kansas City, KS
26 verified pulmonary disease doctors in Kansas City.
Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Damien Stevens, MD
Pulmonary Disease
CMS Open Payments· $62,992 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$62,992
Total received
31
Transactions
5
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Damien Stevens do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Matthias Salathe, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sowjanya Duthuluru, MD
Pulmonary Disease
CMS Open Payments· $137.77 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$137.77
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 62th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Sowjanya Duthuluru do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Aman Khan, MD
Pulmonary Disease
CMS Open Payments· $1,037 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,037
Total received
43
Transactions
18
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 80th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Aman Khan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Timothy Dwyer, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Timothy Williamson, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Susan Pingleton, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Harold Barkman, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mark Hamblin, MD
Pulmonary Disease
CMS Open Payments· $988,697 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$988,697
Total received
79
Transactions
9
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Mark Hamblin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Franklin Quijano, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Steven Stites, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Steven Simpson, MD
Pulmonary Disease
CMS Open Payments· $69.18 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$69.18
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 55th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Steven Simpson do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Joel Mermis, MD
Pulmonary Disease
CMS Open Payments· $96,669 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$96,669
Total received
5
Transactions
2
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Joel Mermis do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Heath Latham, MD
Pulmonary Disease
CMS Open Payments· $57,811 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$57,811
Total received
6
Transactions
3
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Heath Latham do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Matthew Sharpe, MD
Pulmonary Disease
CMS Open Payments· $167,008 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$167,008
Total received
172
Transactions
5
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Matthew Sharpe do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Crosser, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Laura Thomas, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Michelle Homan, DO
Pulmonary Disease
CMS Open Payments· $557.83 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$557.83
Total received
10
Transactions
9
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 74th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Michelle Homan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Chase Hall, MD
Pulmonary Disease
CMS Open Payments· $6,503 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$6,503
Total received
18
Transactions
4
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Chase Hall do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Derek Low, MD
Pulmonary Disease
CMS Open Payments· $293.38 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$293.38
Total received
17
Transactions
8
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 68th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Derek Low do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sahil Pandya, MD
Pulmonary Disease
CMS Open Payments· $249,043 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$249,043
Total received
48
Transactions
2
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Sahil Pandya do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jonathan Chandler, DO
Pulmonary Disease
CMS Open Payments· $173.63 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$173.63
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 64th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Jonathan Chandler do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Abigail Spaedy, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jerry Rodgers, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Joshua Ault, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Craig Beavers, DO
Pulmonary Disease
CMS Open Payments· $111.93 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$111.93
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 59th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Craig Beavers do not imply any wrongdoing. Many are meals, education, or research support.